Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Heerde

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Blood|March 15, 1994
Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to siteP C de Bruin, M Jiwa, J J Oudejans, et al.
Cancer|April 15, 1993
Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosisP C de Bruin, A L Noorduyn, P van der Valk, et al.
Cancer|April 15, 1982
Immunological characterization of non-Hodgkin's lymphoma: enrichment of neoplastic cells from lymphoid tissues and bloodA A Bom-Van Noorloos, A A Van Beek, J Ubels-Postma, et al.
Histopathology|August 1, 1993
Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotypeP C de Bruin, R C Beljaards, P van Heerde, et al.
The British Journal of Ophthalmology|December 1, 1984
Lymphoid proliferations in the orbit: malignant or benign?R van der Gaag, L Koornneef, P van Heerde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthoodF E van Leeuwen, W J Klokman, M B Veer, et al.
Blood|February 15, 1997
Activated cytotoxic T cells as prognostic marker in Hodgkin's diseaseJ J Oudejans, N M Jiwa, J A Kummer, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Blood|March 15, 1994
Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to siteP C de Bruin, M Jiwa, J J Oudejans, et al.
Cancer|April 15, 1993
Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosisP C de Bruin, A L Noorduyn, P van der Valk, et al.
Cancer|April 15, 1982
Immunological characterization of non-Hodgkin's lymphoma: enrichment of neoplastic cells from lymphoid tissues and bloodA A Bom-Van Noorloos, A A Van Beek, J Ubels-Postma, et al.
Histopathology|August 1, 1993
Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotypeP C de Bruin, R C Beljaards, P van Heerde, et al.
The British Journal of Ophthalmology|December 1, 1984
Lymphoid proliferations in the orbit: malignant or benign?R van der Gaag, L Koornneef, P van Heerde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthoodF E van Leeuwen, W J Klokman, M B Veer, et al.
Blood|February 15, 1997
Activated cytotoxic T cells as prognostic marker in Hodgkin's diseaseJ J Oudejans, N M Jiwa, J A Kummer, et al.
Pageof 7